Phase 2 study of KHK7580
Phase 2
- Conditions
- Secondary hyperparathyroidism patients receiving hemodialysis
- Registration Number
- JPRN-jRCT2080222580
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Subjects who have voluntarily consented to participate in this study
- Subjects with stable chronic renal disease receiving hemodialysis 3 times weekly for at least 12 weeks before screening
- Subjects with an intact PTH of >= 240 pg/mL at screening
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy<br>intact PTH
- Secondary Outcome Measures
Name Time Method